PharmaSGP Holding SE (PSG) — Cash Flow Reinvestment Rate
PharmaSGP Holding SE (PSG) has a Cash Flow Reinvestment Rate of 0.34x as of March 2025, reinvesting €1.42 Million (capex €708.00K plus investments €-708.00K) from operating cash flow of €4.22 Million. Explore PSG capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
PharmaSGP Holding SE Cash Flow Reinvestment Rate (2014–2024)
Historical reinvestment intensity for PharmaSGP Holding SE across 11 annual periods. Also explore PharmaSGP Holding SE assets under control for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for PharmaSGP Holding SE (2014–2024)
Year-by-year capital reinvestment analysis for PharmaSGP Holding SE. For live market cap and broader valuation context, see PharmaSGP Holding SE (PSG) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.12x | €2.94 Million | €24.88 Million | €1.47 Million | ▲ +82.0% |
| 2023 | 0.07x | €1.73 Million | €26.64 Million | €866.00K | ▲ +77.2% |
| 2022 | 0.04x | €907.00K | €24.71 Million | €120.00K | ▼ -99.5% |
| 2021 | 6.83x | €83.55 Million | €12.24 Million | €94.00K | ▲ +7906.1% |
| 2020 | 0.09x | €1.32 Million | €15.46 Million | €420.00K | ▲ +102.1% |
| 2019 | 0.04x | €744.00K | €17.63 Million | €420.00K | ▲ +29.8% |
| 2018 | 0.03x | €274.00K | €8.43 Million | €274.00K | ▼ -45.4% |
| 2017 | 0.06x | €848.00K | €14.25 Million | €397.00K | ▼ -98.6% |
| 2016 | 4.35x | €15.43 Million | €3.55 Million | €11.88 Million | ▲ +914.8% |
| 2015 | 0.43x | €4.54 Million | €10.59 Million | €4.26 Million | ▼ -35.7% |
| 2014 | 0.67x | €3.60 Million | €5.41 Million | €2.01 Million | — |